To assess the effectiveness of our deconvolution, we first examined the three receptor genes associated with molecular subtypes of breast cancer: the oestrogen receptor (ESR1), progesterone receptor (PGR), and human epidermal growth factor receptor 2 (ERBB2). This evidence concerns the gene PGR and breast carcinoma.